Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Femasys, Hemovent, Masimo, Neuspera, Rapidai, Syantra.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerin Medical, Audere, Bioinnovation Institute, Boomerang, Ferring, Guardant, Humancyte, Lucid Diagnostics, Lumicell, Mend Nutrition, Opgen, Sapphiros.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cedar Gate, Life Spine, Memed, Monteris Medical, Pison Technology.

Med-tech firms raising money in public or private financings, including: Mediwhale, Toku, Xenocor.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 2seventy, Abbvie, Affamed, Bristol Myers Squibb, Candel, Hanchorbio, Intelgenx, Lundbeck, Novo Nordisk, Otsuka.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acadia, Alkermes, Altemia, Araris, ARS, Awakn, Coeptis, Daewoong, Deverra, Lobe, Nektar, Neophore, Neuren, Sygnature, Tiziana.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrocyte, Gritstone, GSK, Immutep, Inovio, Kiora, Minervax, Neurosense, Peptilogics, Quralis, Rallybio, Relief, Shionogi, Umecrine, Vaxcyte, Xbiotech.

Biopharmas raising money in public or private financings, including: Ariceum, Athersys, Biocryst, Epic Bio, Spexis, Vaxcyte.

New hires and promotions in the biopharma industry, including: Abivax, AACR, Hi-Bio, Intellia, Marinus, Ocelot, Recode, RS, Tessera.

The top 10 med-tech stock gainers and losers for the week.